← Back to Search

Procedure

Otago exercises for Chronic Disease (ReabFalls Trial)

N/A
Waitlist Available
Led By Rubens da Silva
Research Sponsored by Université du Québec à Chicoutimi
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 65 and over
Admitted to La Baie Hospital rehabilitation services
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 8 to 12 weeks
Awards & highlights

ReabFalls Trial Summary

This trial will test a new program to prevent falls in older adults with neuro-musculoskeletal disorders. It aims to reduce hospitalization & deaths due to falls, and lower public health costs.

Who is the study for?
This trial is for older adults with neuro-musculoskeletal disorders and a risk of falling, such as those with Parkinson's disease or chronic lower back pain. Participants should be experiencing issues that increase their chances of falls and may already be under geriatric care.Check my eligibility
What is being tested?
The study tests a new exercise program called OTAGO against conventional therapy to manage fall risks in the elderly. It involves creating patient profiles, diagnosing functional deficits using high-tech tools, evaluating the effectiveness of OTAGO exercises, and assessing satisfaction.See study design
What are the potential side effects?
Since this trial involves physical exercises designed for older adults at risk of falling, potential side effects might include muscle soreness or strain. However, these are typically mild and manageable within a rehabilitation setting.

ReabFalls Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.
Select...
I am admitted to La Baie Hospital for rehabilitation.

ReabFalls Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 8 to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 8 to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Machine learning-driven neuromusculoskeletal (NMS) assessment
Postural control
Trunk postural control on wobble chair
+1 more
Secondary outcome measures
30 Second Sit to Stand Test
5 times Sit-To-Stand (FTSTS)
Functional mobility test: TUG
+3 more
Other outcome measures
Cognitive status
Falls Efficacy Scale-International (FES-I)
Fatigue perception
+3 more

ReabFalls Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Otago exercisesExperimental Treatment1 Intervention
OTAGO program - based on very specific exercises for balance, force, and muscular endurance as well as on education about the risk of falling. The program is considered as "home care" (exercises to be done at home) but will be done as a group and with supervision, at CIUSSS or from outdoor and nature intervention (recreactional parks). OTAGO session lasts for 30-40 minutes and will be done twice a week at sites with progression. The program is comprised of 5 muscle strengthening exercises and 12 postural balance exercises. Participants will also be invited to walk 2 times per week for 30 minutes (can be divided into shorter periods, for example 3 blocs of 10 minutes) from outdoor sites or recrative parks. According to each person's strength and mobility, exercises will be increased with the use of free weights (for example during squats) and/or by increasing the number of repetitions. Total duration of the program will be 3 months (i.e., a duration adapted to the site).
Group II: Conventional physiotherapy at HospitalActive Control1 Intervention
This group will be for the conventional type of intervention already in place in geriatric services from La Baie Hospital. This therapy used for physiotherapists at site, including mobility exercices.

Find a Location

Who is running the clinical trial?

Agence de la Sante et des Services Sociaux du Saguenay-Lac-Saint-JeanOTHER
3 Previous Clinical Trials
1,531 Total Patients Enrolled
1 Trials studying Chronic Disease
247 Patients Enrolled for Chronic Disease
Université du Québec à ChicoutimiLead Sponsor
4 Previous Clinical Trials
182 Total Patients Enrolled
Julie Bouchard, PhDStudy DirectorUniversité du Québec à Chicoutimi

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria are necessary for someone to be eligible to participate in the trial?

"This medical study is searching for 92 participants aged between 65 and 99 years old, who are suffering from musculoskeletal ailments."

Answered by AI

Are recruitment efforts still underway for this clinical trial?

"Clinicaltrials.gov has stated that this particular study, which was posted on July 1st 2024 and last updated December 8th 2023, is not currently enrolling patients. However, 1005 other clinical trials are actively searching for participants at present."

Answered by AI

Is the participant age limit for this research greater than 30?

"The qualifications for this clinical trial fixate on elderly patients, aged between 65 and 99 years. There are 55 trials focusing on younger individuals under 18, while 896 studies target the senior population."

Answered by AI

What specific aims are being pursued in this clinical trial?

"The primary result being measured over the 8-12 week period is walking speed, which was assessed using a 10 meter test. Additionally, maximal isometric hand grip strength was estimated with Jamar dynamometers and corrected for body mass index via Fried classification; 30 second sit to stand tests were utilized as part of the Fullerton Functional Fitness Test Battery in order to overcome floor effects when assessing older adults."

Answered by AI
~61 spots leftby Jul 2025